Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM) José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;

Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study J. Emilio Sanchez-Alvarez; Elena Astudillo Cortés; Miguel Seras Mozas; Raúl García Castro; Carlos Miguel Hidalgo Ordoñez; Ana Cristina Andrade López; Catalina Ulloa Clavijo; Anna Gallardo Pérez; Carmen Rodríguez Suarez;

Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study María Auxiliadora Bajo; Francisco Ríos-Moreno; Maria Dolores Arenas; Ramón Jesús Devesa-Such; Maria Jose Molina-Higueras; Margarita Delgado; Pablo Molina; Nuria García-Fernández; Alejandro Martin-Malo; Roser Peiró-Jordán; Jorge Cannata-Andia; Ángel Luis Martín-De Francisco;